Unknown

Dataset Information

0

Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study.


ABSTRACT: INTRODUCTION:Two risk minimization (RM) tools-a healthcare professional frequently asked questions (HCP-FAQs) brochure and a patient/caregiver information brochure (PCIB)-were developed for HCPs and for adolescents (aged???13 years) receiving aripiprazole for bipolar I mania and their caregivers. OBJECTIVES:This study evaluated the effectiveness of these RM tools in improving the awareness and education of HCPs and patients/caregivers. METHOD:The RM tools were distributed to HCPs (identified in agreement with the marketing authorization holder [MAH] and local regulatory authorities), who in turn distributed the PCIBs to patients/caregivers. A web-based survey was then conducted targeting HCPs and patients/caregivers. RESULTS:The response rate was low: 118 of 23,282 invited HCPs and 16 patients/caregivers completed the survey. Overall, 42% (49/118) of HCP respondents were aware of aripiprazole RM tools; of these, 59% (29/49) of HCPs read them at least once and 66% (19/29) of these used the RM tools while discussing the benefit-risk profile of aripiprazole with patients/caregivers. In total, 30 of the 118 HCPs (25%) were aware of the PCIB, and 26 distributed it to their patients/caregivers, whereas seven HCPs advised them to read the brochure. Overall, 15 of the 16 patients/caregivers were aware of the PCIB, and 13 read/referred to it. Of these, 12 found the PCIB useful, and five monitored their weight while receiving aripiprazole and reported potential risks immediately to their HCP. CONCLUSION:The response rate to the survey was low, and the tools displayed limited utility and effectiveness in improving awareness and education in a small number of responders. Therefore, the aripiprazole risk management plan was amended, and the tools were discontinued.

SUBMITTER: Landsberg W 

PROVIDER: S-EPMC6061424 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study.

Landsberg Wally W   Al-Dakkak Imad I   Coppin-Renz Antonia A   Geis Uli U   Peters-Strickland Timothy T   van Heumen Emiel E   Rahman Mirza M  

Drug safety 20180801 8


<h4>Introduction</h4>Two risk minimization (RM) tools-a healthcare professional frequently asked questions (HCP-FAQs) brochure and a patient/caregiver information brochure (PCIB)-were developed for HCPs and for adolescents (aged ≥ 13 years) receiving aripiprazole for bipolar I mania and their caregivers.<h4>Objectives</h4>This study evaluated the effectiveness of these RM tools in improving the awareness and education of HCPs and patients/caregivers.<h4>Method</h4>The RM tools were distributed t  ...[more]

Similar Datasets

| S-EPMC8668858 | biostudies-literature
| S-EPMC6055865 | biostudies-other
| S-EPMC7581670 | biostudies-literature
| S-EPMC10948458 | biostudies-literature
| S-EPMC8238922 | biostudies-literature
| S-EPMC8744394 | biostudies-literature
| S-EPMC9303697 | biostudies-literature
| S-EPMC3457002 | biostudies-literature
| S-EPMC7979585 | biostudies-literature
| S-EPMC6175151 | biostudies-literature